Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells.

Source:http://linkedlifedata.com/resource/pubmed/id/8402715

Download in:

View as

General Info

PMID
8402715